Literature DB >> 23052923

Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy.

Nobue Saito1, Yutaka Imai, Takashi Muto, Toshimi Sairenchi.   

Abstract

PURPOSE: The association between body mass index (BMI) and oral mucositis in oral cancer patients receiving radiotherapy is unclear. This study examined whether low BMI could be a risk factor for oral mucositis in oral cancer patients receiving radiotherapy.
METHODS: Between April 2007 and March 2011, a total of 33 inpatients with oral cancer receiving radiotherapy were recruited. They were followed from the beginning of radiotherapy to discharge from hospital. All patients had no mucositis when radiotherapy started. The odds ratio (OR) and 95 % confidence interval (CI) of BMI for incident grade 2 and grade 3 mucositis were calculated by use of univariable logistic regression models.
RESULTS: All patients developed oral mucositis (grade 1 in 39.4 %, grade 2 in 30.3 %, grade 3 in 30.3 %), with the maximum grade occurring at an average of 32.4 days. Compared with normal BMI (≥22.0), the OR of low BMI (<22.0) for moderate to severe mucositis was 9.07 (95 % CI, 1.72-47.68).
CONCLUSIONS: Low BMI may be a risk factor of moderate to severe oral mucositis.

Entities:  

Mesh:

Year:  2012        PMID: 23052923     DOI: 10.1007/s00520-012-1620-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

Review 1.  Oral complications of cancer therapies. Description and incidence of oral complications.

Authors:  S Dreizen
Journal:  NCI Monogr       Date:  1990

2.  Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil.

Authors:  G M McCarthy; J D Awde; H Ghandi; M Vincent; W I Kocha
Journal:  Oral Oncol       Date:  1998-11       Impact factor: 5.337

3.  Impact of obesity on surgical outcomes after colorectal resection.

Authors:  S Benoist; Y Panis; A Alves; P Valleur
Journal:  Am J Surg       Date:  2000-04       Impact factor: 2.565

4.  Severity of oral mucositis correlates with the response of oral cancer to preoperative radiochemotherapy.

Authors:  T Ikebe; K Seki; S Nakamura; Y Takenoshita; H Nakayama; M Shinohara; K Shirasuna
Journal:  Int J Oral Maxillofac Surg       Date:  2005-09       Impact factor: 2.789

Review 5.  Current practices for management of oral mucositis in cancer patients.

Authors:  J E Raber-Durlacher
Journal:  Support Care Cancer       Date:  1999-03       Impact factor: 3.603

6.  Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases.

Authors:  J E Raber-Durlacher; N I Weijl; M Abu Saris; B de Koning; A H Zwinderman; S Osanto
Journal:  Support Care Cancer       Date:  2000-09       Impact factor: 3.603

Review 7.  Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

Authors:  Andy Trotti; Lisa A Bellm; Joel B Epstein; Diana Frame; Henry J Fuchs; Clement K Gwede; Eugene Komaroff; Luba Nalysnyk; Marya D Zilberberg
Journal:  Radiother Oncol       Date:  2003-03       Impact factor: 6.280

8.  Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial.

Authors:  A Kazemian; S Kamian; M Aghili; F A Hashemi; P Haddad
Journal:  Eur J Cancer Care (Engl)       Date:  2009-03       Impact factor: 2.520

Review 9.  Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.

Authors:  S T Sonis
Journal:  Oral Oncol       Date:  1998-01       Impact factor: 5.337

10.  Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

Authors:  Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna R Hollis; A David McCollum; Denise Brady; Michael J O'Connell; Robert J Mayer; Bernard Cummings; Christopher Willett; John S Macdonald; Al B Benson; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

View more
  9 in total

1.  Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.

Authors:  Chih-Jen Huang; Ming-Yii Huang; Pen-Tzu Fang; Frank Chen; Yu-Tsang Wang; Chung-Ho Chen; Shyng-Shiou Yuan; Chun-Ming Huang; Kuei-Hau Luo; Hung-Yi Chuang; Yen-Yun Wang; Hsin-Hua Lee
Journal:  Am J Clin Nutr       Date:  2019-03-01       Impact factor: 7.045

2.  Comparison of methods for the handling of metallic dental restorations before head and neck radiotherapy.

Authors:  Toshihiro Motoi; Takahiko Oho
Journal:  Support Care Cancer       Date:  2022-10-14       Impact factor: 3.359

3.  The relationship of serum gastrin-17 and oral mucositis in head and neck carcinoma patients receiving radiotherapy.

Authors:  Congye Wu; Yehong Liu; Feiyue Shi; Fei Chen; Yongcai Zhao; Huanyu Zhao
Journal:  Discov Oncol       Date:  2022-10-21

4.  Nutritional Status and Its Association With Radiation-Induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma During Radiotherapy: A Prospective Study.

Authors:  Zekai Shu; Ziyi Zeng; Bingqi Yu; Shuang Huang; Yonghong Hua; Ting Jin; Changjuan Tao; Lei Wang; Caineng Cao; Zumin Xu; Qifeng Jin; Feng Jiang; Xinglai Feng; Yongfeng Piao; Jing Huang; Jia Chen; Wei Shen; Xiaozhong Chen; Hui Wu; Xiushen Wang; Rongliang Qiu; Lixia Lu; Yuanyuan Chen
Journal:  Front Oncol       Date:  2020-11-06       Impact factor: 6.244

5.  Differences in quality of life in obese and normal weight head and neck cancer patients undergoing radiation therapy.

Authors:  Helen Egestad; Carsten Nieder
Journal:  Support Care Cancer       Date:  2014-10-04       Impact factor: 3.603

6.  Incidence and Risk Factors of Oral Mucositis in Patients with Breast Cancer Who Receiving Chemotherapy in Al-Bashir Hospital.

Authors:  Ahmed A Al Ibraheemi; Shaimaa Shamoun
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01

7.  Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients.

Authors:  Kensuke Yoshida; Yasumitsu Kodama; Yusuke Tanaka; Kyongsun Pak; Marie Soga; Akira Toyama; Kouji Katsura; Ritsuo Takagi
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

Review 8.  Confounding factors in the assessment of oral mucositis in head and neck cancer.

Authors:  Luigi Lorini; Francesco Perri; Stefania Vecchio; Liliana Belgioia; Marie Vinches; Irene Brana; Sharon Elad; Paolo Bossi
Journal:  Support Care Cancer       Date:  2022-05-31       Impact factor: 3.359

9.  Factors associated with acute oral mucosal reaction induced by radiotherapy in head and neck squamous cell carcinoma: A retrospective single-center experience.

Authors:  Zhenchao Tao; Jin Gao; Liting Qian; Yifan Huang; Yan Zhou; Liping Yang; Jian He; Jing Yang; Ru Wang; Yangyang Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.